The Role of Dysbiosis of Intestinal Microbiota in the Development of Spondyloarthritis

摘要

2021 MAY 05 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - Staff editors report on the newly launched clinical trial, NCT04853212, which has the following summary description: "The primary objective of this case-control study aims to explore the role of bacterium Ruminococcus gnavus (R. gnavus) with intestinal biopsy and faecal sampling in the initiation and the development of spondyloarthritis (SPA) in comparison with health control subjets (patients without chronic disease but have indication to digestive endoscopy)."